Dr. Pikman on Matching Pediatric Patients With More Precise Leukemia Therapy

Yana Pikman, MD
Published: Thursday, Dec 27, 2018



Yana Pikman, MD, a physician in the Cancer and Blood Disorders Center at Dana-Farber Cancer Institute and instructor of pediatrics at Harvard Medical School, discusses a trial attempting to match pediatric patients with more precise therapy for acute leukemia. Early findings were reported at the 2018 ASH Annual Meeting.

At the time of enrollment, pediatric patients had a sample of their leukemia sequenced and those data were reviewed by a panel of pediatric oncologists, therapeutic experts, and pathologists. Pikman says this process was to determine if researchers were able to identify any targetable mutations. If a targetable recommendation was made, the information was passed along to try to match a corresponding therapy.

This was a feasibility study, and Pikman says the next steps would include therapeutic studies testing the efficacy of the targeted agents. Researchers are discovering a number of novel genomic findings and identifying their significance to see whether therapy can be tailored towards them.
SELECTED
LANGUAGE


Yana Pikman, MD, a physician in the Cancer and Blood Disorders Center at Dana-Farber Cancer Institute and instructor of pediatrics at Harvard Medical School, discusses a trial attempting to match pediatric patients with more precise therapy for acute leukemia. Early findings were reported at the 2018 ASH Annual Meeting.

At the time of enrollment, pediatric patients had a sample of their leukemia sequenced and those data were reviewed by a panel of pediatric oncologists, therapeutic experts, and pathologists. Pikman says this process was to determine if researchers were able to identify any targetable mutations. If a targetable recommendation was made, the information was passed along to try to match a corresponding therapy.

This was a feasibility study, and Pikman says the next steps would include therapeutic studies testing the efficacy of the targeted agents. Researchers are discovering a number of novel genomic findings and identifying their significance to see whether therapy can be tailored towards them.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Community Practice Connections: Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology CareJan 31, 20191.5
Publication Bottom Border
Border Publication
x